SCHEMBL19426176

SCHEMBL19426176

CNC(=O)C(NO)c1cc(Cl)c(O)c(O)c1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ HSPA1A P0DMV8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19426175 0.78 FFAR2 (0.34) ADRA2AADRA2CADRA1AFFAR2
SCHEMBL19426169 0.75 CYP1A2 (0.36) KMT2AHIF1ACYP1A2ALOX15ALOX12
SCHEMBL15631276 0.68 GABRA1 (0.52) KMT2AHIF1AMEN1NPC1USP2
SCHEMBL19426172 0.68 ADRA2A (0.46) CYP3A4ADRA2AMAPTADRA2CPTGS1
SCHEMBL19426180 0.67 POLB (0.38) KMT2AMEN1LMNACYP1A2POLB
SCHEMBL15495181 0.66 WDR5 (0.41) KMT2AHIF1AMEN1NPC1USP2
SCHEMBL19426170 0.66 ADRA2A (0.49) ADRA2AADRA2CADRA1A
SCHEMBL17193121 0.65 AKR1C2 (0.33) KMT2AHIF1AMEN1NPC1USP2
SCHEMBL19426173 0.64 ADRB1 (0.43) KMT2AHIF1AMEN1LMNACYP1A2
SCHEMBL15680668 0.64 AKR1C2 (0.35) KMT2AHIF1AMEN1NPC1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170281532-A1 2 SUBSTITUTED CEPHEM COMPOUNDS GLAXO GROUP LIMITED (GB) 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281532-A1 2 SUBSTITUTED CEPHEM COMPOUNDS CEP170, CES2, CMBL KMT2A 1116/4885HIF1A 3653/4885MEN1 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback